Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the ...
Strong efficacy signals showing 33% ORR, 16.6-month PFS, and 27-month OS, improving on the SOC by 2-3X in a ...
The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.
The FDA has granted fast track designation to the investigational oncolytic virus immunotherapy pelareorep (Reolysin) in combination with bevacizumab (Avastin) and FOLFIRI (leucovorin, fluorouracil, ...
Pancreatic cancer may evade the immune system not by accident but by actively switching off internal danger signals through ...
Beyond the convenience of a quick meal lies a growing concern among oncologists—highly processed frozen staples may be silent ...
Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.
A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.